Lacticaseibacillus rhamnosus
Lacticaseibacillus rhamnosus, most widely studied as the GG strain, has an extensive research record, though the evidence base in this index is predominantly in vitro and animal-model work. Laboratory studies have examined intestinal barrier integrity and antimicrobial activity against certain pathogens, including mechanisms such as bioactive peptides and pilus-mediated adhesion. A 2022 scoping review examined supplementation effects on children's health across food and non-food delivery formats. The broader clinical picture remains early-stage, and findings from cell and animal studies do not establish proven human health outcomes. These are research topics, not findings; the papers do not establish that this strain treats or prevents any condition.
Where it's been studied Tags come from a conservative keyword scan of each paper's title, abstract, and summary. A tag is research coverage, not measured effect. How we classify this →
Share of this strain's 2,746 body-system-tagged papers that concern each system. Research coverage, not measured effect.
Symptoms in the research A tag means the paper's text names the symptom or condition — research coverage, not evidence of benefit. How we classify this →
Share of this strain's 1,066 symptom-tagged papers that mention each symptom or condition. Research coverage, not evidence of benefit.
+17 more symptoms
Strains of this species
20 strains of Lacticaseibacillus rhamnosus in the index, with 4,269 linked papers between them.
Lacticaseibacillus rhamnosus MTCC 5462
Lacticaseibacillus rhamnosus MTCC 5462 is an Indian deposited strain whose published research base is composed entirely of in vitro and genomic studies.
Lacticaseibacillus rhamnosus GG
Lacticaseibacillus rhamnosus GG (LGG) is one of the most extensively studied probiotic strains globally, though the papers linked to this strain entry focus primarily on encapsulation technology and formulation stability…
Lacticaseibacillus rhamnosus HN001
Lacticaseibacillus rhamnosus HN001 (formerly classified as Lactobacillus rhamnosus HN001) has been studied across in vitro, animal, and human randomized controlled trial settings.
Lacticaseibacillus rhamnosus R0011
Lacticaseibacillus rhamnosus R0011 is a well-studied probiotic strain with a research base spanning food technology, immunology, and gut health.
Lacticaseibacillus rhamnosus Lcr35
Lacticaseibacillus rhamnosus Lcr35 (formerly Lactobacillus casei rhamnosus Lcr35) has been evaluated in several randomized controlled trials across distinct clinical contexts, including pediatric chronic constipation, va…
Lacticaseibacillus rhamnosus GR-1
Lacticaseibacillus rhamnosus GR-1 is among the most thoroughly researched probiotic strains for urogenital health, with multiple randomized controlled trials evaluating its oral use in relation to vaginal microbiota comp…
Lacticaseibacillus rhamnosus Lr-32
Lacticaseibacillus rhamnosus LR-32 appears in the indexed literature primarily as a component of multi-strain probiotic formulations.
Lacticaseibacillus rhamnosus LRa05
Lacticaseibacillus rhamnosus LRa05 is an emerging probiotic strain with a growing evidence base spanning animal models and several randomized controlled trials.
Lacticaseibacillus rhamnosus LRH10
Lacticaseibacillus rhamnosus LRH10 is a strain of L.
Lacticaseibacillus rhamnosus LB21
Lacticaseibacillus rhamnosus LB21 is a strain with a modest body of published research, primarily focused on oral microbiome interactions.
Lacticaseibacillus rhamnosus DSM 14870
Lacticaseibacillus rhamnosus DSM 14870 (also known as L.
Lacticaseibacillus rhamnosus PB01
Lacticaseibacillus rhamnosus PB01 is a lactic acid bacterium studied for its antimicrobial and metabolic properties.
Lacticaseibacillus rhamnosus LR06
Lacticaseibacillus rhamnosus LR06 appears primarily as a component of multi-strain probiotic formulations, where it has been studied alongside other bacterial species in randomized controlled trials.
Lacticaseibacillus rhamnosus LOCK0900
Lacticaseibacillus rhamnosus LOCK0900 (formerly Lactobacillus rhamnosus LOCK900) is a strain that has been explored for use in fermented meat products and studied in vitro for its potential effects on intestinal epitheli…
Lacticaseibacillus rhamnosus SP1
Lacticaseibacillus rhamnosus SP1 has been studied in multiple randomized controlled trials with a notable focus on oral health.
Lacticaseibacillus rhamnosus CNCM I-4036
Lacticaseibacillus rhamnosus CNCM I-4036 was originally isolated from the feces of exclusively breastfed infants and has since been studied alongside two companion strains (L.
Lacticaseibacillus rhamnosus CECT 8361
Lacticaseibacillus rhamnosus CECT 8361 has a modest research base, with evidence drawn from two randomized controlled trials in which it was used as part of a multi-strain formulation.
Lacticaseibacillus rhamnosus CECT 8362
Lacticaseibacillus rhamnosus CECT 8362 is a strain of the well-studied rhamnosus species deposited in the Spanish Type Culture Collection (CECT).
Lacticaseibacillus rhamnosus LR
Lacticaseibacillus rhamnosus LR appears in a range of in vitro and animal studies spanning oral health, gut barrier function, and metabolic research, areas consistent with the broader L.
Lacticaseibacillus rhamnosus UCO-25A
Lacticaseibacillus rhamnosus UCO-25A is a lactic acid bacterium isolated from human gastric sources.
Research Study-type filters use AI-classified labels, audited but not guaranteed — check the paper itself before leaning on one. How we classify this →
5597 papers reference this strain in the probiotic database.
Discussion
Be the first to comment.
Sign in to join the discussion.
Citations
Selected papers that name this strain.
-
[1]
Source →ROLE OF LACTOBACILLUS RHAMNOSUS PROBIOTIC IN THE TREATMENT AND PREVENTION OF RECURRENCE OF BACTERIAL VAGINOSIS· Zenodo (CERN European Organization for Nuclear Research) · 2026
-
[2]
Source →Randomized, Double-Blind, Placebo-Controlled Clinical Trial Assessing the Efficacy of Lacticaseibacillus rhamnosus CRL 1505 in Preventing Upper Respiratory Tract Infections in Healthy Adults· Microorganisms · 2026
-
[3]
PMID 42076937 →Probiotics Augment the Effect of Non‐Surgical Periodontal Treatment—A Randomised, Double‐Blinded, Placebo‐Controlled Trial· Journal Of Clinical Periodontology · 2026
-
[4]
PMID 41971606 →Multi‐Strain Probiotics BLa80, LRa05, and BBr60 Modulate Inflammation, Bile Acids, and Gut Microbiota in Type 2 Diabetes: A Randomized Controlled Trial· Food Science & Nutrition · 2026
-
[5]
PMID 42080229 →Impact of Probiotics on Children with Acute Gastroenteritis: Results from an Umbrella Meta-Analysis· Journal of Integrative and Complementary Medicine · 2026
-
[6]
Source →Probiotici u pedijatrijskoj gastroenterologiji· Paediatria Croatica · 2026
-
[7]
PMID 42138226 →Probiotics in the alleviation of food allergies in infants and young children: research progress· Critical Reviews in Food Science and Nutrition · 2026
-
[8]
Source →Current Treatment Strategies and Effectiveness of Adjunct Therapy in the Treatment of Recurrent Bacterial Vaginosis· Digital Showcase Research, Scholarship, & Creative Works (University of Lynchburg) · 2026
-
[9]
PMID 41683053 →Improving Lipid Profiles Through Lactobacillus rhamnosus Supplementation in Dyslipidemic Animal Models: A Systematic Review and Meta-Analysis· Foods · 2026
-
[10]
PMID 40005019 →Augmenting Cognitive Function in the Elderly with Mild Cognitive Impairment Using Probiotic Lacticaseibacillus rhamnosus CBT-LR5: A 12-Week Randomized, Double-Blind, Parallel-Group Non-Comparative Study· Nutrients · 2025